Rozman C, Carreras E, Qian C, Gale R P, Bortin M M, Rowlings P A, Ash R C, Champlin R E, Henslee-Downey P J, Herzig R H, Hinterberger W, Klein J P, Prentice H G, Reiffers J, Zwaan F E, Horowitz M M
Health Policy Institute, Medical College of Wisconsin 53226, USA.
Bone Marrow Transplant. 1996 Jan;17(1):75-80.
The objective was to analyze risk factors for veno-occlusive disease of the liver (VOD) after allogeneic bone marrow transplantation. A cohort of 1717 recipients of HLA-identical sibling transplants for leukemia between 1988 and 1990, in 200 transplant teams worldwide, was studied. Patients were scored as having VOD if liver tissue showed typical histologic features or if they had all three of the following: (1) jaundice; (2) hepatomegaly and right upper quadrant abdominal pain; and (3) ascites and/or unexplained weight gain. Patients surviving more than 7 days post-transplant without histologic or any of these clinical features of VOD were classified as not having VOD. Patient-, disease- and transplant-related characteristics of 95 patients with VOD were compared to those of 1514 without VOD. Variables correlated with an increased risk of VOD were: pretransplant conditioning with busulfan and cyclophosphamide compared to total body radiation (relative risk (RR) 2.8; P < 0.0001), pretransplant fungal infection (RR 4.1; P = 0.011), pretransplant Karnofsky performance score < 90% (RR 1.9; P = 0.012), prior liver disease (RR 1.9; P = 0.05) and age > 20 years (RR 1.8; P = 0.05). In patients receiving radiation for conditioning, intravenous immune globulin decreased VOD risk (RR 0.26; P = 0.003). This analysis identifies risk factors for VOD. The data suggest several strategies for modifying transplant regimens to reduce VOD risk and which patients might be suitable subjects for trials of strategies of VOD prevention.
目的是分析异基因骨髓移植后肝静脉闭塞病(VOD)的危险因素。对1988年至1990年间全球200个移植团队中1717例接受 HLA 相同同胞白血病移植的受者进行了队列研究。如果肝组织显示典型的组织学特征,或者患者具备以下全部三项:(1)黄疸;(2)肝肿大和右上腹疼痛;(3)腹水和/或无法解释的体重增加,则将患者判定为患有VOD。移植后存活超过7天且无VOD组织学或任何这些临床特征的患者被分类为未患VOD。将95例VOD患者的患者、疾病和移植相关特征与1514例无VOD患者的特征进行了比较。与VOD风险增加相关的变量有:与全身放疗相比,移植前用白消安和环磷酰胺预处理(相对风险(RR)2.8;P < 0.0001)、移植前真菌感染(RR 4.1;P = 0.011)、移植前卡诺夫斯基性能评分< 90%(RR 1.9;P = 0.012)、既往肝病(RR 1.9;P = 0.05)以及年龄> 20岁(RR 1.8;P = 0.05)。在接受放疗预处理的患者中,静脉注射免疫球蛋白降低了VOD风险(RR 0.26;P = 0.003)。该分析确定了VOD的危险因素。数据提示了几种调整移植方案以降低VOD风险的策略,以及哪些患者可能是VOD预防策略试验的合适对象。